These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 20688485

  • 1. Genotypic analysis of plasmid-mediated beta-lactamases amongst Enterobacteriaceae other than Escherichia spp. and Klebsiella spp. that are non-susceptible to a broad-spectrum cephalosporin.
    Kiratisin P, Henprasert A.
    Int J Antimicrob Agents; 2010 Oct; 36(4):343-7. PubMed ID: 20688485
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens.
    Pfeifer Y, Cullik A, Witte W.
    Int J Med Microbiol; 2010 Aug; 300(6):371-9. PubMed ID: 20537585
    [Abstract] [Full Text] [Related]

  • 4. The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter.
    Livermore DM, Woodford N.
    Trends Microbiol; 2006 Sep; 14(9):413-20. PubMed ID: 16876996
    [Abstract] [Full Text] [Related]

  • 5. Detection of extended-spectrum beta-lactamases by using boronic acid as an AmpC beta-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli.
    Song W, Bae IK, Lee YN, Lee CH, Lee SH, Jeong SH.
    J Clin Microbiol; 2007 Apr; 45(4):1180-4. PubMed ID: 17301276
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Association of QnrB determinants and production of extended-spectrum beta-lactamases or plasmid-mediated AmpC beta-lactamases in clinical isolates of Klebsiella pneumoniae.
    Pai H, Seo MR, Choi TY.
    Antimicrob Agents Chemother; 2007 Jan; 51(1):366-8. PubMed ID: 17074790
    [Abstract] [Full Text] [Related]

  • 9. Resistance phenotype-genotype correlation and molecular epidemiology of Citrobacter, Enterobacter, Proteus, Providencia, Salmonella and Serratia that carry extended-spectrum β-lactamases with or without plasmid-mediated AmpC β-lactamase genes in Thailand.
    Kiratisin P, Henprasert A.
    Trans R Soc Trop Med Hyg; 2011 Jan; 105(1):46-51. PubMed ID: 20880563
    [Abstract] [Full Text] [Related]

  • 10. Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis.
    Song W, Jeong SH, Kim JS, Kim HS, Shin DH, Roh KH, Lee KM.
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3):315-8. PubMed ID: 17174510
    [Abstract] [Full Text] [Related]

  • 11. Characterization of TEM-, SHV- and AmpC-type beta-lactamases from cephalosporin-resistant Enterobacteriaceae isolated from swine.
    Rayamajhi N, Kang SG, Lee DY, Kang ML, Lee SI, Park KY, Lee HS, Yoo HS.
    Int J Food Microbiol; 2008 May 31; 124(2):183-7. PubMed ID: 18455821
    [Abstract] [Full Text] [Related]

  • 12. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
    Nijssen S, Florijn A, Bonten MJ, Schmitz FJ, Verhoef J, Fluit AC.
    Int J Antimicrob Agents; 2004 Dec 31; 24(6):585-91. PubMed ID: 15555882
    [Abstract] [Full Text] [Related]

  • 13. Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases.
    Pfaller MA, Segreti J.
    Clin Infect Dis; 2006 Apr 15; 42 Suppl 4():S153-63. PubMed ID: 16544266
    [Abstract] [Full Text] [Related]

  • 14. Plasmid-Mediated AmpC β-Lactamase and Underestimation of Extended-Spectrum β-Lactamase in Cefepime-Susceptible Elevated-Ceftazidime-MIC Enterobacteriaceae Isolates.
    Nishimura F, Morinaga Y, Akamatsu N, Matsuda J, Kaku N, Takeda K, Uno N, Kosai K, Hasegawa H, Yanagihara K.
    Jpn J Infect Dis; 2018 Jul 24; 71(4):281-285. PubMed ID: 29709981
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S, Warner M, Ge Y, Kaniga K, Livermore DM.
    J Antimicrob Chemother; 2007 Aug 24; 60(2):300-11. PubMed ID: 17548456
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England.
    Potz NA, Hope R, Warner M, Johnson AP, Livermore DM, London & South East ESBL Project Group.
    J Antimicrob Chemother; 2006 Aug 24; 58(2):320-6. PubMed ID: 16735428
    [Abstract] [Full Text] [Related]

  • 17. Faecal colonization of E. coli and Klebsiella spp. producing extended-spectrum beta-lactamases and plasmid-mediated AmpC in Mozambican university students.
    Chirindze LM, Zimba TF, Sekyere JO, Govinden U, Chenia HY, Sundsfjord A, Essack SY, Simonsen GS.
    BMC Infect Dis; 2018 May 30; 18(1):244. PubMed ID: 29843632
    [Abstract] [Full Text] [Related]

  • 18. Characteristics of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates from horses.
    Vo AT, van Duijkeren E, Fluit AC, Gaastra W.
    Vet Microbiol; 2007 Oct 06; 124(3-4):248-55. PubMed ID: 17521833
    [Abstract] [Full Text] [Related]

  • 19. Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents.
    Mendes RE, Rhomberg PR, Bell JM, Turnidge JD, Sader HS.
    Diagn Microbiol Infect Dis; 2009 Apr 06; 63(4):415-25. PubMed ID: 19249175
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.
    Moland ES, Hanson ND, Black JA, Hossain A, Song W, Thomson KS.
    J Clin Microbiol; 2006 Sep 06; 44(9):3318-24. PubMed ID: 16954267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.